Last reviewed · How we verify
Placebo of PR tablet — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of PR tablet (Placebo of PR tablet) — Reckitt Benckiser Healthcare (UK) Limited. A placebo tablet contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of PR tablet TARGET | Placebo of PR tablet | Reckitt Benckiser Healthcare (UK) Limited | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of PR tablet CI watch — RSS
- Placebo of PR tablet CI watch — Atom
- Placebo of PR tablet CI watch — JSON
- Placebo of PR tablet alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of PR tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-pr-tablet. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab